242 related articles for article (PubMed ID: 9742086)
1. Regulation of Mdm2-directed degradation by the C terminus of p53.
Kubbutat MH; Ludwig RL; Ashcroft M; Vousden KH
Mol Cell Biol; 1998 Oct; 18(10):5690-8. PubMed ID: 9742086
[TBL] [Abstract][Full Text] [Related]
2. MDM2 can promote the ubiquitination, nuclear export, and degradation of p53 in the absence of direct binding.
Inoue T; Geyer RK; Howard D; Yu ZK; Maki CG
J Biol Chem; 2001 Nov; 276(48):45255-60. PubMed ID: 11572869
[TBL] [Abstract][Full Text] [Related]
3. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.
Rodriguez MS; Desterro JM; Lain S; Lane DP; Hay RT
Mol Cell Biol; 2000 Nov; 20(22):8458-67. PubMed ID: 11046142
[TBL] [Abstract][Full Text] [Related]
4. Oligomerization is required for p53 to be efficiently ubiquitinated by MDM2.
Maki CG
J Biol Chem; 1999 Jun; 274(23):16531-5. PubMed ID: 10347217
[TBL] [Abstract][Full Text] [Related]
5. Identification of p53 sequence elements that are required for MDM2-mediated nuclear export.
Gu J; Nie L; Wiederschain D; Yuan ZM
Mol Cell Biol; 2001 Dec; 21(24):8533-46. PubMed ID: 11713288
[TBL] [Abstract][Full Text] [Related]
6. MdmX protects p53 from Mdm2-mediated degradation.
Jackson MW; Berberich SJ
Mol Cell Biol; 2000 Feb; 20(3):1001-7. PubMed ID: 10629057
[TBL] [Abstract][Full Text] [Related]
7. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.
Wang C; Ivanov A; Chen L; Fredericks WJ; Seto E; Rauscher FJ; Chen J
EMBO J; 2005 Sep; 24(18):3279-90. PubMed ID: 16107876
[TBL] [Abstract][Full Text] [Related]
8. Proteasomal degradation of p53 by human papillomavirus E6 oncoprotein relies on the structural integrity of p53 core domain.
Bernard X; Robinson P; Nominé Y; Masson M; Charbonnier S; Ramirez-Ramos JR; Deryckere F; Travé G; Orfanoudakis G
PLoS One; 2011; 6(10):e25981. PubMed ID: 22046250
[TBL] [Abstract][Full Text] [Related]
9. Oligomerisation of full length p53 contributes to the interaction with mdm2 but not HPV E6.
Marston NJ; Jenkins JR; Vousden KH
Oncogene; 1995 May; 10(9):1709-15. PubMed ID: 7753547
[TBL] [Abstract][Full Text] [Related]
10. The MDM2 RING-finger domain is required to promote p53 nuclear export.
Geyer RK; Yu ZK; Maki CG
Nat Cell Biol; 2000 Sep; 2(9):569-73. PubMed ID: 10980696
[TBL] [Abstract][Full Text] [Related]
11. The tumor suppressor p53 and the oncoprotein simian virus 40 T antigen bind to overlapping domains on the MDM2 protein.
Brown DR; Deb S; Muñoz RM; Subler MA; Deb SP
Mol Cell Biol; 1993 Nov; 13(11):6849-57. PubMed ID: 8413278
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the degradation function of Mdm2.
Kubbutat MH; Ludwig RL; Levine AJ; Vousden KH
Cell Growth Differ; 1999 Feb; 10(2):87-92. PubMed ID: 10074902
[TBL] [Abstract][Full Text] [Related]
13. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6.
Freedman DA; Levine AJ
Mol Cell Biol; 1998 Dec; 18(12):7288-93. PubMed ID: 9819415
[TBL] [Abstract][Full Text] [Related]
14. Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination.
O'Keefe K; Li H; Zhang Y
Mol Cell Biol; 2003 Sep; 23(18):6396-405. PubMed ID: 12944468
[TBL] [Abstract][Full Text] [Related]
15. c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination.
Sionov RV; Coen S; Goldberg Z; Berger M; Bercovich B; Ben-Neriah Y; Ciechanover A; Haupt Y
Mol Cell Biol; 2001 Sep; 21(17):5869-78. PubMed ID: 11486026
[TBL] [Abstract][Full Text] [Related]
16. Physical and functional interactions between PML and MDM2.
Wei X; Yu ZK; Ramalingam A; Grossman SR; Yu JH; Bloch DB; Maki CG
J Biol Chem; 2003 Aug; 278(31):29288-97. PubMed ID: 12759344
[TBL] [Abstract][Full Text] [Related]
17. Critical roles for the serine 20, but not the serine 15, phosphorylation site and for the polyproline domain in regulating p53 turnover.
Dumaz N; Milne DM; Jardine LJ; Meek DW
Biochem J; 2001 Oct; 359(Pt 2):459-64. PubMed ID: 11583595
[TBL] [Abstract][Full Text] [Related]
18. Subcellular distribution of p53 and p73 are differentially regulated by MDM2.
Gu J; Nie L; Kawai H; Yuan ZM
Cancer Res; 2001 Sep; 61(18):6703-7. PubMed ID: 11559539
[TBL] [Abstract][Full Text] [Related]
19. p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products.
Yin Y; Stephen CW; Luciani MG; Fåhraeus R
Nat Cell Biol; 2002 Jun; 4(6):462-7. PubMed ID: 12032546
[TBL] [Abstract][Full Text] [Related]
20. Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein.
Liu WL; Midgley C; Stephen C; Saville M; Lane DP
J Mol Biol; 2001 Nov; 313(4):711-31. PubMed ID: 11697899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
